The official journal of the Particle Therapy Co-Operative Group (PTCOG), the International Journal of Particle Therapy, is now indexed in PubMed Central, beginning with the Winter 2016 Carbon Ion Special Issue. Launched in 2014, the journal’s mission is to provide a preferred venue for disseminating the most up-to-date research in proton, light-ion and heavy charged-particle therapy.
PTCOG is the non-profit, worldwide organization of scientists and professionals interested in proton, light-ion and heavy charged-particle radiotherapy. The mission of PTCOG is to promote science, technology and practical clinical application of particle therapy through continuing education, international conferences and scientific meetings, with the ultimate goal of improving treatment of cancer to the highest possible standards in radiation therapy.
PubMed Central is a free full-text archive of biomedical and life sciences journal literature at the U.S. National Institutes of Health’s National Library of Medicine (NIH/NLM).
“We are extremely proud of IJPT’s achievements thus far,” said Nancy Mendenhall, MD, FASTRO, editor-in-chief of the IJPT. “In particular, our acceptance by the National Library of Medicine – which utilizes a meticulous selection process examining our scientific and editorial quality and impact – reflects our important role in the overall advancement of particle therapy research.”
Since its founding, IJPT has received manuscripts from nearly 300 prominent radiation oncologists, physicists, and dosimetrists from 200 institutions around the world. IJPT is a quarterly, open access journal that does not charge any article submission or processing fees. Articles are also digitally archived by Scopus, Portico, J-Gate, EBSCOhost, Google Scholar, and the Directory of Open Access Journals.
Visit https://www.ptcog.ch/ for more information on the Particle Therapy Co-Operative Group. Visit https://theijpt.org/ to view all issues of IJPT and for more information on the journal.